Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Sigachi Industries's net current asset value per share for the quarter that ended in Jun. 2026 was ₹0.00.
The historical rank and industry rank for Sigachi Industries's Net Current Asset Value or its related term are showing as below:
NSE:SIGACHI'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 7.36 Med: 11.47 Max: 42.11
Current: 16.56
During the past 8 years, the highest Price-to-Net-Current-Asset-Value Ratio of Sigachi Industries was 42.11. The lowest was 7.36. And the median was 11.47.
NSE:SIGACHI's Price-to-Net-Current-Asset-Value is ranked worse than 79.8% of 604
companies
in the Drug Manufacturers industry
Industry Median: 6.03
vs NSE:SIGACHI: 16.56
Sigachi Industries (NSE:SIGACHI) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Sigachi Industries Net Current Asset Value Related Terms
Sigachi Industries Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Sigachi Industries's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SIGACHI vs ZTS: Net Current Asset Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sigachi Industries's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigachi Industries Price-to-Net-Current-Asset-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sigachi Industries's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Sigachi Industries's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ₹0.00 mean?
Sigachi Industries (NSE:SIGACHI) has a Net Current Asset Value of ₹0.00 as of Jun. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Sigachi Industries and its competitors. Over the past decade, Sigachi Industries' Net Current Asset Value has ranged from 7.36 to 42.11. According to the industry distribution chart, Sigachi Industries ranks #482 out of 604 companies in the Drug Manufacturers industry, placing it in the top 79.8%.
Is Sigachi Industries' Net Current Asset Value too high?
Sigachi Industries' current Net Current Asset Value is ₹0.00. Over the past 10 years, this metric has ranged from a low of 7.36 to a high of 42.11. Based on the distribution chart, Sigachi Industries ranks #482 out of 604 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sigachi Industries has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sigachi Industries' Net Current Asset Value compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sigachi Industries ranks #482 out of 604 companies for Net Current Asset Value. This places Sigachi Industries in the lower half of its industry. The industry median Net Current Asset Value is 6.03. Historically, Sigachi Industries' own Net Current Asset Value has ranged from 7.36 to 42.11 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Drug Manufacturers company?
The median Net Current Asset Value among Drug Manufacturers companies is 6.03, based on 604 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Sigachi Industries and its competitors. For the Drug Manufacturers industry, the median Net Current Asset Value is 6.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sigachi Industries's current Net Current Asset Value is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigachi Industries stock overvalued right now?
Based on GuruFocus' analysis, Sigachi Industries (NSE:SIGACHI) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹46.86, compared to a current price of ₹30.31 — trading 35.3% below its estimated fair value. The current Net Current Asset Value is ₹0.00. Sigachi Industries' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Sigachi Industries (NSE:SIGACHI), the current Net Current Asset Value is ₹0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sigachi Industries (NSE:SIGACHI) Overvalued in 2026?
Based on GuruFocus' analysis, Sigachi Industries stock appears to be undervalued.
The current stock price of ₹30.31 is trading 35.3% below its estimated GF Value™ of ₹46.86.
GuruFocus considers Sigachi Industries to be Significantly Undervalued.
Key valuation signals for NSE:SIGACHI:
Net Current Asset Value: ₹0.00
GF Value™: ₹46.86 vs. price of ₹30.31 (35.3% below fair value)
No single metric tells the full story. See the NSE:SIGACHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sigachi Industries Ltd is engaged in the manufacturing of Microcrystalline Cellulose (MCC), which is widely used as an excipient for finished dosages in the pharmaceutical industry. The Company is mainly pursuing only one activity which is manufacturing and selling of MCC. The company manufactures MCC of various grades ranging from 15 microns to 250 microns and the crucial grades of MCC manufactured and marketed by the company are branded as HiCel and AceCel.
83GF Score
Get the complete analysis for NSE:SIGACHI
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SIGACHI has been successfully added to your 
